A FOUR PART STUDY TO INVESTIGATE RELATIVE BIOAVAILABILITY, SAFETY AND TOLERABILITY OF UP TO 5 ORAL FORMULATION OF GSK2251052 IN ORDER TO IDENTIFY A FORMULATION FOR FURTHER EVALUATION IN A FUTURE LATER PHASE STUDY: